It is appropriate to create new pharmaceutical products within developing countries.
Arguments are presented for utilizing local product development as an appropriate way to solve many of the current medical problems of the Third World. Guidelines for selecting problems amenable to this approach are provided, and the risks attendant on such an activity outlined. It is suggested that organizations such as the World Health Organization can encourage this approach by helping to provide training in product development and by providing consulting services for organizations in the developing world.